These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30585839)

  • 21. Are current guidelines adapted for patient eligibility to PrEP? A case report.
    Van Obberghen EK; Viard D; Lafeuillade A; Civiletti A; Rocher F; Drici MD
    BMC Infect Dis; 2019 Jul; 19(1):601. PubMed ID: 31291899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
    Venter F; Allais L; Richter M
    Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe.
    Coleman R; Prins M
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067904
    [No Abstract]   [Full Text] [Related]  

  • 25. Using data from a behavioural survey of men who have sex with men (MSM) to estimate the number likely to present for HIV pre-exposure prophylaxis (PrEP) in Ireland, 2017.
    Nic Lochlainn L; O'Donnell K; Hurley C; Lyons F; Igoe D
    Euro Surveill; 2017 Nov; 22(48):. PubMed ID: 29208157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.
    Nikolopoulos GK; Christaki E; Paraskevis D; Bonovas S
    Curr Pharm Des; 2017; 23(18):2579-2591. PubMed ID: 28356043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland.
    Siedner MJ; Hettema A; Hughey A; Oldenburg CE; Kohler S; Bärnighausen K; McMahon S; Jia C; Lejeune C; Matse S; Bärnighausen T
    AIDS; 2018 Jul; 32(11):1541-1542. PubMed ID: 29794832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.
    Oldenburg CE; Le B; Toan T; Thien DD; Huyen HT; Friedman MR; Stall R; Colby D
    AIDS Behav; 2016 Dec; 20(Suppl 3):365-370. PubMed ID: 27435073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOVING FORWARD WITH PrEP. THE BASICS OF PrEP.
    Highleyman L
    Posit Aware; 2015; 27(5):2-3. PubMed ID: 26714333
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-Exposure Prophylaxis (PrEP): Can HIV be Prevented?
    Salter D
    Ala Nurse; 2015 Dec; 42(4):6. PubMed ID: 26749943
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
    Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
    AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.
    Blumenthal J; Jain S; Krakower D; Sun X; Young J; Mayer K; Haubrich R;
    AIDS Behav; 2015 May; 19(5):802-10. PubMed ID: 25616837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance.
    van Tienen C; van de Vijver D; Noori T; Sönnerborg A; Boucher C
    Euro Surveill; 2017 Mar; 22(11):. PubMed ID: 28333614
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
    Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.